Table 3.

The Relation Between the Studied LncRNAs and Tumor Characteristics Among HCC Cases

	HCC cases N = 60		Linc00152		UCA1
	No	%	Mean ±SD	Test (p value)	Mean ±SD	Test (p value)
Vascular invasion
Yes	12	20.0	2.78±1.31	0.03 (0.98)	2.29±0.53	2.40 (0.01)*
No	48	80.0	2.89±1.01		1.85±0.45
LN metastasis
Yes	12	20.0	3.38±0.95	1.78 (0.08)	2.12±0.57	0.65 (0.52)
No	48	80.0	2.74±1.07		2.23±0.54
Tumor number
Single	22	36.7	2.70±1.17	0.53 (0.60)	2.18±0.63	0.23 (0.82)
Multiple	38	63.3	2.97±1.0		2.22±0.49
Tumor size
<3 cm	14	23.3	3.20±0.88	1.40 (0.50)	2.08±0.44	1.41 (0.49)
3–5	24	40.0	2.83±1.05		2.45±0.56
>5 cm	22	36.7	2.71±1.19		2.24±0.59
Tumor site
RT	32	53.3	2.66±1.11	7.91 (0.02)*	2.16±0.56	0.34 (0.84)
LT	16	26.7	2.70±1.10		2.30±0.51
Both	12	20	3.66±0.35		2.20±0.56
TNM staging
Stage I–II	16	26.7	2.58± 0.58		2.388± 0.58
Stage III–IV	44	73.3	2.13± 0.5	299 (0.38)	2.17±0.34	238 (0.06)
BCLC staging
A	38	63.3	2.80±1.01		1.99±0.52
B	22	36.7	2.99±1.18	0.72 (0.47)	2.33±0.52	2.18 (0.03)*

Note: *Statistically significant at p ≤ 0.05.

Abbreviations: LN, Lymph node; TNM, tumour, node, metastasis; BCLC, Barcelona Clinic Liver Cancer.